Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00200
Species: Homo sapiens
Position : chr2:178806313-178806949
Year: 2024
Title: Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: dilated cardiomyopathy
PMID:  39688912
MONDO: MONDO:0005021
Tissue: heart
Tissue Ontology ID: UBERON:0000948
Cell Source: human induced pluripotent stem cell-derived cardiomyocytes
Cell Type: cardiac muscle cell
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer activity assay; endogenous enhancer perturbation; TF motif functional assay; target-gene expression assay; phenotypic assay; TF binding assay; Disease-variant functional analysis; In vivo functional validation
High Throughput Method: ATAC-seq; MPRA; single-nucleus RNA-seq
Low Throughput Method: CRISPR/Cas9 E0/E1 deletion; GFP reporter assay; MEF2-site mutagenesis; transgenic mouse reporter assay; RT-qPCR; Western blot; sarcomere analysis; engineered cardiac microtissue contractility assay; Site-directed/motif mutagenesis; Allele-specific reporter assay; Mouse genetic deletion/knock-in; In vivo phenotyping
About Target Gene
Target gene : TTN
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 5 found
Enhancer ID Position Tissue Cell Disease
E_00001 chr2:178806313-178806949 heart cardiac muscle cell dilated cardiomyopathy
E_00002 chr2:178806313-178806949 heart cardiac muscle cell dilated cardiomyopathy
E_00052 chr2:178806313-178806949 heart cardiac muscle cell NA
E_00154 chr2:178806313-178806949 heart cardiac muscle cell dilated cardiomyopathy
E_00387 chr2:178806313-178806949 heart cardiac muscle cell dilated cardiomyopathy
Expression of Target Genes for the Enhancer